HR 796 · in committee · niche
Second Chance for Moms Act
- reproductive rights
What this bill does
- The bill requires mifepristone drug labels to include information about the hormone progesterone.
- Patients and healthcare providers using mifepristone for medication abortion are affected.
- The bill establishes a telephone hotline related to progesterone information.
Generated by claude-haiku-4-5
Community Threads
Started by Cosponsor
- 01
How would adding progesterone information to mifepristone labels affect patient decision-making and healthcare provider counseling practices?
- 02
What evidence supports the connection between progesterone supplementation and reversing medication abortion effects?
- 03
Who would fund and staff the proposed progesterone information hotline, and what would be its specific role?
Cosponsor writes these to seed civic discussion — they aren't user posts. Sign in to reply.
Sponsor · R-IL-15
Mary E. Miller
Citizen cosponsors
0
In Congress
13/ 435
House Reps cosponsoring
Introduced 2025-01-28
Joining the bill
Randy K. Weber, Sr.
R-TX-14 · original
Andrew Ogles
R-TN-5 · original
Claudia Tenney
R-NY-24 · original
Daniel Webster
R-FL-11 · original
Brian Babin
R-TX-36 · original
Andrew S. Clyde
R-GA-9 · original
Andy Harris
R-MD-1 · original
Barry Moore
R-AL-1 · original
Riley M. Moore
R-WV-2 · original
Mark Harris
R-NC-8
Gary J. Palmer
R-AL-6
John W. Rose
R-TN-6
+ 1 more
Legislative timeline
2025-01-28 · house · IntroReferral
Referred to the House Committee on Energy and Commerce.
2025-01-28 · IntroReferral
Introduced in House
2025-01-28 · IntroReferral
Introduced in House
Citizen comments
Sign in to comment on this bill.
No comments yet — be the first.